NYC pharma startup wants to turn LSD into…

“…I want nothing to do with those kinds of folks who want to decriminalize psychedelics,” he says [a 32-year-old former Uber employee and co-founder].

…[he is part of] one of many companies trying to repurpose hallucinogenic molecules as the next blockbuster drug… has acquired the exclusive rights to eight clinical trials that are exploring the medicinal properties of the powerful hallucinogen lysergic acid diethylamide (LSD)… deal gives [company] a 10-year exclusive collaboration.

Original Article (Merry Jane):
This New York City pharma startup wants to turn LSD into an FDA-approved medicine for anxiety disorder
Artwork Fair Use: Public Domain